- Tytuł:
- A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
- Autorzy:
- Źródło:
- In Vaccine 30 April 2024 42(12):3066-3074
Czasopismo naukowe